Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Thomas

Showing results (271-280 of 441) with videos related to

Pageof 45
Sort By:
Hepatology (Baltimore, Md.)|March 18, 2009
SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis CGiada Sebastiani, Philippe Halfon, Laurent Castera, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2009
Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfectionGregory D Kirk, Jacquie Astemborski, Shruti H Mehta, et al.
The Journal of Infectious Diseases|March 30, 2012
The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study designPeter Vickerman, Jason Grebely, Gregory J Dore, et al.
Journal of Viral Hepatitis|October 15, 2025
Impact of Risk Heterogeneity on the Feasibility of Hepatitis C Elimination Among People Who Inject Drugs: A Modelling StudyKyra H Grantz, Derek A T Cummings, Luis Mier-Y-Teran Romero, et al.
Magnetic Resonance in Medicine|October 25, 2023
ASL lexicon and reporting recommendations: A consensus report from the ISMRM Open Science Initiative for Perfusion Imaging (OSIPI)Yuriko Suzuki, Patricia Clement, Weiying Dai, et al.
The Journal of Infectious Diseases|May 14, 2025
Multiple approaches to genetic sequencing to identify hepatitis C virus reinfection among people who inject drugsKyra H Grantz, Raghavendran Anantharam, Abraham J Kandathil, et al.
Journal of Viral Hepatitis|June 29, 2023
Geographic variation in HCV treatment penetration among people who inject drugs in Baltimore, MDCatelyn R Coyle, Michael R Desjardins, Frank C Curriero, et al.
Antiviral Therapy|June 26, 2015
IFNL3 genotype is associated with differential induction of IFNL3 in primary human hepatocytesFuat Kurbanov, Yonghak Kim, Rachel Latanich, et al.
Journal of Virology|April 23, 2002
HLA-Cw*04 and hepatitis C virus persistenceChloe L Thio, Xiaojiang Gao, James J Goedert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2026
Updated hepatitis D seroprevalence among HBsAg-positive persons aged ≥6 years in the United States, National Health and Nutrition Examination Survey, 2007‒2018Shannon M Casillas, Asiya Chida, Jan Drobeniuc, et al.
Pageof 45

Showing results (271-280 of 441) with videos related to

Sort By:
Pageof 45
Hepatology (Baltimore, Md.)|March 18, 2009
SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis CGiada Sebastiani, Philippe Halfon, Laurent Castera, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2009
Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfectionGregory D Kirk, Jacquie Astemborski, Shruti H Mehta, et al.
The Journal of Infectious Diseases|March 30, 2012
The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study designPeter Vickerman, Jason Grebely, Gregory J Dore, et al.
Journal of Viral Hepatitis|October 15, 2025
Impact of Risk Heterogeneity on the Feasibility of Hepatitis C Elimination Among People Who Inject Drugs: A Modelling StudyKyra H Grantz, Derek A T Cummings, Luis Mier-Y-Teran Romero, et al.
Magnetic Resonance in Medicine|October 25, 2023
ASL lexicon and reporting recommendations: A consensus report from the ISMRM Open Science Initiative for Perfusion Imaging (OSIPI)Yuriko Suzuki, Patricia Clement, Weiying Dai, et al.
The Journal of Infectious Diseases|May 14, 2025
Multiple approaches to genetic sequencing to identify hepatitis C virus reinfection among people who inject drugsKyra H Grantz, Raghavendran Anantharam, Abraham J Kandathil, et al.
Journal of Viral Hepatitis|June 29, 2023
Geographic variation in HCV treatment penetration among people who inject drugs in Baltimore, MDCatelyn R Coyle, Michael R Desjardins, Frank C Curriero, et al.
Antiviral Therapy|June 26, 2015
IFNL3 genotype is associated with differential induction of IFNL3 in primary human hepatocytesFuat Kurbanov, Yonghak Kim, Rachel Latanich, et al.
Journal of Virology|April 23, 2002
HLA-Cw*04 and hepatitis C virus persistenceChloe L Thio, Xiaojiang Gao, James J Goedert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2026
Updated hepatitis D seroprevalence among HBsAg-positive persons aged ≥6 years in the United States, National Health and Nutrition Examination Survey, 2007‒2018Shannon M Casillas, Asiya Chida, Jan Drobeniuc, et al.
Pageof 45